TEST BANK
Pharmacology: A Patient-Centered Nursing Process Approach, 10 th Edition
BY
Linda E. McCuistion
,Pharmacology a patient-centered nursing process approach 10th edition by linda e. mc
cuistion
Table of content
Pharmacology a patient-centered nursing process approach 10th edition by linda e. mc cuistion ........................ 1
Chapter 01: The Nursing Process and Patient-Centered Care .............................................................................. 4
Chapter 02: Drug Development and Ethical Considerations .............................................................................. 10
Chapter 03: Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics -................................................... 18
Chapter 04: Pharmacogenetics ........................................................................................................................... 32
Chapter 05: Complementary and Alternative Therapies .................................................................................... 35
Chapter 06: Pediatric Considerations ................................................................................................................. 40
Chapter 07: Geriatric Considerations ................................................................................................................. 47
Chapter 08: Drugs of Abuse ............................................................................................................................... 53
Chapter 09: Safety and Quality .......................................................................................................................... 59
Chapter 10: Drug Administration ....................................................................................................................... 65
Chapter 11: Drug Calculations ........................................................................................................................... 70
Chapter 12: Fluid Volume and Electrolytes ....................................................................................................... 75
Chapter 13: Vitamin and Mineral Replacement ................................................................................................. 84
Chapter 14: Nutritional Support ......................................................................................................................... 91
Chapter 15: Adrenergic Agonists and Antagonists ............................................................................................ 99
Chapter 16: Cholinergic Agonists and Antagonists ......................................................................................... 105
Chapter 17: Stimulants ..................................................................................................................................... 111
Chapter 18: Depressants ................................................................................................................................... 115
Chapter 19: Antiseizure Drugs ......................................................................................................................... 121
Chapter 20: Drugs for Parkinson Disease and Alzheimer Disease................................................................... 128
Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms - .......................................................... 134
Chapter 22 Transplant Drugs............................................................................................................................ 141
Chapter 23: Vaccines ........................................................................................................................................ 144
Chapter 24: Anticancer Drugs .......................................................................................................................... 148
Chapter 25: Targeted Therapies to Treat Cancer.............................................................................................. 152
Chapter 26: Biologic Response Modifiers........................................................................................................ 155
Chapter 27: Upper Respiratory Disorders ........................................................................................................ 159
Chapter 28: Lower Respiratory Disorders ........................................................................................................ 163
Chapter 28: Cardiac Glycosides, Antianginals, and Antidysrhythmics - ......................................................... 169
Chapter 29: Diuretics........................................................................................................................................ 176
Chapter 30: Antihypertensives ......................................................................................................................... 180
Chapter 31: Anticoagulants, Antiplatelets, and Thrombolytics........................................................................ 186
,Chapter 32: Antihyperlipidemics and Peripheral Vasodilators ........................................................................ 193
Chapter 33: Gastrointestinal Tract Disorders ................................................................................................... 198
Chapter 34: Antiulcer Drugs ............................................................................................................................ 204
Chapter 35: Eye and Ear Disorders .................................................................................................................. 210
Chapter 36: Dermatologic Disorders ................................................................................................................ 214
Chapter 37: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders - ............................................................. 219
Chapter 38: Antidiabetics ................................................................................................................................. 226
Chapter 39: Urinary Disorders ......................................................................................................................... 233
Chapter 40: Pregnancy and Preterm Labor....................................................................................................... 238
Chapter 41: Labor, Delivery, and Postpartum .................................................................................................. 244
Chapter 42: Neonatal and Newborn ................................................................................................................. 249
Chapter 43: Women’s Reproductive Health ..................................................................................................... 251
Chapter 44: Men’s Reproductive Health .......................................................................................................... 257
Chapter 45: Sexually Transmitted Infections ................................................................................................... 261
Chapter 46: Adult and Pediatric Emergency Drugs ......................................................................................... 264
, Chapter 01: The Nursing Process and Patient-Centered Care
MULTIPLE CHOICE
1. The nursing process is a five-step decision-making approach that includes all of the following
steps, EXCEPT:
a. Assessment
b. Patient problem
c. Planning
d. Right Drug
ANS: D
The nursing process is a five-step decision-making approach that includes: 1) assessment, 2)
patient problem, 3) planning, 4) implementation, and 5) evaluation. “Right drug” is one of the
“Six Rights” of medication administration.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning
MSC: NCLEX: Management of Care
2. The nurse is using data collected to set goals or expected outcomes and interventions that
address the patient’s problems. Which step of the nursing process is the nurse applying?
a. Assessment
b. Patient problem
c. Planning
d. Evaluation
ANS: C
During the planning phase, the nurse uses the data collected to set goals or expected outcomes
and interventions which address the patient’s problems. The data was collected during the
“Assessment” and “Patient problem” steps. During the “Evaluation” phase the nurse would
determine whether the goals and objectives set during the planning phase were met.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management of Care
3. A 5-year-old child with type 1 diabetes mellitus has had repeated hospitalizations for episodes
of hyperglycemia. The parents tell the nurse that they can’t keep track of everything that has
to be done to care for their child. The nurse reviews medications, diet, and symptom
management with the parents and draws up a daily checklist for the family to use. These
activities are completed in which step of the nursing process?
a. Assessment
b. Planning
c. Implementation
d. Evaluation
ANS: C
Pharmacology: A Patient-Centered Nursing Process Approach, 10 th Edition
BY
Linda E. McCuistion
,Pharmacology a patient-centered nursing process approach 10th edition by linda e. mc
cuistion
Table of content
Pharmacology a patient-centered nursing process approach 10th edition by linda e. mc cuistion ........................ 1
Chapter 01: The Nursing Process and Patient-Centered Care .............................................................................. 4
Chapter 02: Drug Development and Ethical Considerations .............................................................................. 10
Chapter 03: Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics -................................................... 18
Chapter 04: Pharmacogenetics ........................................................................................................................... 32
Chapter 05: Complementary and Alternative Therapies .................................................................................... 35
Chapter 06: Pediatric Considerations ................................................................................................................. 40
Chapter 07: Geriatric Considerations ................................................................................................................. 47
Chapter 08: Drugs of Abuse ............................................................................................................................... 53
Chapter 09: Safety and Quality .......................................................................................................................... 59
Chapter 10: Drug Administration ....................................................................................................................... 65
Chapter 11: Drug Calculations ........................................................................................................................... 70
Chapter 12: Fluid Volume and Electrolytes ....................................................................................................... 75
Chapter 13: Vitamin and Mineral Replacement ................................................................................................. 84
Chapter 14: Nutritional Support ......................................................................................................................... 91
Chapter 15: Adrenergic Agonists and Antagonists ............................................................................................ 99
Chapter 16: Cholinergic Agonists and Antagonists ......................................................................................... 105
Chapter 17: Stimulants ..................................................................................................................................... 111
Chapter 18: Depressants ................................................................................................................................... 115
Chapter 19: Antiseizure Drugs ......................................................................................................................... 121
Chapter 20: Drugs for Parkinson Disease and Alzheimer Disease................................................................... 128
Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms - .......................................................... 134
Chapter 22 Transplant Drugs............................................................................................................................ 141
Chapter 23: Vaccines ........................................................................................................................................ 144
Chapter 24: Anticancer Drugs .......................................................................................................................... 148
Chapter 25: Targeted Therapies to Treat Cancer.............................................................................................. 152
Chapter 26: Biologic Response Modifiers........................................................................................................ 155
Chapter 27: Upper Respiratory Disorders ........................................................................................................ 159
Chapter 28: Lower Respiratory Disorders ........................................................................................................ 163
Chapter 28: Cardiac Glycosides, Antianginals, and Antidysrhythmics - ......................................................... 169
Chapter 29: Diuretics........................................................................................................................................ 176
Chapter 30: Antihypertensives ......................................................................................................................... 180
Chapter 31: Anticoagulants, Antiplatelets, and Thrombolytics........................................................................ 186
,Chapter 32: Antihyperlipidemics and Peripheral Vasodilators ........................................................................ 193
Chapter 33: Gastrointestinal Tract Disorders ................................................................................................... 198
Chapter 34: Antiulcer Drugs ............................................................................................................................ 204
Chapter 35: Eye and Ear Disorders .................................................................................................................. 210
Chapter 36: Dermatologic Disorders ................................................................................................................ 214
Chapter 37: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders - ............................................................. 219
Chapter 38: Antidiabetics ................................................................................................................................. 226
Chapter 39: Urinary Disorders ......................................................................................................................... 233
Chapter 40: Pregnancy and Preterm Labor....................................................................................................... 238
Chapter 41: Labor, Delivery, and Postpartum .................................................................................................. 244
Chapter 42: Neonatal and Newborn ................................................................................................................. 249
Chapter 43: Women’s Reproductive Health ..................................................................................................... 251
Chapter 44: Men’s Reproductive Health .......................................................................................................... 257
Chapter 45: Sexually Transmitted Infections ................................................................................................... 261
Chapter 46: Adult and Pediatric Emergency Drugs ......................................................................................... 264
, Chapter 01: The Nursing Process and Patient-Centered Care
MULTIPLE CHOICE
1. The nursing process is a five-step decision-making approach that includes all of the following
steps, EXCEPT:
a. Assessment
b. Patient problem
c. Planning
d. Right Drug
ANS: D
The nursing process is a five-step decision-making approach that includes: 1) assessment, 2)
patient problem, 3) planning, 4) implementation, and 5) evaluation. “Right drug” is one of the
“Six Rights” of medication administration.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning
MSC: NCLEX: Management of Care
2. The nurse is using data collected to set goals or expected outcomes and interventions that
address the patient’s problems. Which step of the nursing process is the nurse applying?
a. Assessment
b. Patient problem
c. Planning
d. Evaluation
ANS: C
During the planning phase, the nurse uses the data collected to set goals or expected outcomes
and interventions which address the patient’s problems. The data was collected during the
“Assessment” and “Patient problem” steps. During the “Evaluation” phase the nurse would
determine whether the goals and objectives set during the planning phase were met.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management of Care
3. A 5-year-old child with type 1 diabetes mellitus has had repeated hospitalizations for episodes
of hyperglycemia. The parents tell the nurse that they can’t keep track of everything that has
to be done to care for their child. The nurse reviews medications, diet, and symptom
management with the parents and draws up a daily checklist for the family to use. These
activities are completed in which step of the nursing process?
a. Assessment
b. Planning
c. Implementation
d. Evaluation
ANS: C
